IL115383A0 - Methods of inhibiting endometrial mitoses - Google Patents

Methods of inhibiting endometrial mitoses

Info

Publication number
IL115383A0
IL115383A0 IL11538395A IL11538395A IL115383A0 IL 115383 A0 IL115383 A0 IL 115383A0 IL 11538395 A IL11538395 A IL 11538395A IL 11538395 A IL11538395 A IL 11538395A IL 115383 A0 IL115383 A0 IL 115383A0
Authority
IL
Israel
Prior art keywords
methods
inhibiting endometrial
mitoses
endometrial mitoses
inhibiting
Prior art date
Application number
IL11538395A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL115383A0 publication Critical patent/IL115383A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11538395A 1994-09-22 1995-09-21 Methods of inhibiting endometrial mitoses IL115383A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/310,292 US5843964A (en) 1994-09-22 1994-09-22 Methods of inhibiting endometrial mitoses

Publications (1)

Publication Number Publication Date
IL115383A0 true IL115383A0 (en) 1995-12-31

Family

ID=23201835

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11538395A IL115383A0 (en) 1994-09-22 1995-09-21 Methods of inhibiting endometrial mitoses

Country Status (16)

Country Link
US (1) US5843964A (zh)
EP (1) EP0782446A4 (zh)
JP (1) JPH10506108A (zh)
KR (1) KR970706000A (zh)
CN (1) CN1158086A (zh)
AU (1) AU692309B2 (zh)
CA (1) CA2200451A1 (zh)
CZ (1) CZ83997A3 (zh)
FI (1) FI971197A0 (zh)
HU (1) HUT76828A (zh)
IL (1) IL115383A0 (zh)
MX (1) MX9702148A (zh)
NO (1) NO971029L (zh)
NZ (1) NZ294123A (zh)
WO (1) WO1996009050A1 (zh)
ZA (1) ZA957949B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0777476A4 (en) * 1994-08-22 1999-06-23 Lilly Co Eli METHODS FOR PREVENTING UTERUS CANCER
ES2246234T3 (es) 1999-05-04 2006-02-16 Strakan International Limited Glicosidos de androgenos y actividad androgenica de los mismos.
USD692738S1 (en) 2011-06-30 2013-11-05 Hellermanntyton Corporation Cable tie tensioning and cut-off tool
PL2726229T3 (pl) 2011-06-30 2016-11-30 Narzędzie do napinania i odcinania opasek kablowych
EP3230167B1 (en) 2014-12-12 2020-03-25 Hellermanntyton Corporation Compound tension and calibration mechanism for cable tie tensioning and cut-off tool

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
WO1996005832A1 (en) * 1994-08-22 1996-02-29 Eli Lilly And Company Methods of inhibiting primary endometrial hyperplasia

Also Published As

Publication number Publication date
US5843964A (en) 1998-12-01
AU692309B2 (en) 1998-06-04
HUT76828A (en) 1997-11-28
JPH10506108A (ja) 1998-06-16
EP0782446A4 (en) 1999-01-07
KR970706000A (ko) 1997-11-03
CA2200451A1 (en) 1996-03-28
CN1158086A (zh) 1997-08-27
FI971197A (fi) 1997-03-21
ZA957949B (en) 1997-03-20
FI971197A0 (fi) 1997-03-21
NO971029D0 (no) 1997-03-06
AU3678895A (en) 1996-04-09
NZ294123A (en) 1999-09-29
CZ83997A3 (en) 1997-07-16
EP0782446A1 (en) 1997-07-09
NO971029L (no) 1997-03-06
WO1996009050A1 (en) 1996-03-28
MX9702148A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
PL322549A1 (en) Inhibitors of proteinous farnesiltransferase
PL327569A1 (en) Promedications of thrombosin inhibitors
PL331254A1 (en) Phosphonianic inhibitors of matrix metaloproteases
PL329875A1 (en) Derivatives of carbolin
PL329195A1 (en) Derivatives of 6-phenylpyridol-2-amine
EP0772592A4 (en) PLA 2 INHIBITORS? WITH 1H-INDOLE FUNCTIONALITY IN POSITION 1
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
PL311736A1 (en) Derivatives of 1h-imidazoles
EP0835109A4 (en) PYRIDINONE-BASED THROMBIN INHIBITORS
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EP0960191A4 (en) COMPOSITIONS AND METHODS FOR THE USE OF DEFENSIN
PL331920A1 (en) Spirocyclic inhibitors of metaloproteases
PL331803A1 (en) Bidonoric metaloprotease inhibitors
EP0913404A4 (en) DIFFERENTIATION INHIBITOR
GB9400538D0 (en) Hydrate inhibition
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9503783D0 (en) Squvalen syntetase inhibitors
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
IL115383A0 (en) Methods of inhibiting endometrial mitoses
HU9702479D0 (en) New polymorphe modification of doxazosin-mesylate
IL115022A0 (en) Methods of inhibiting endometrial cancer
DE69523450D1 (en) Inhibitor
GB9505865D0 (en) Hydrate Inhibitors